Content area

Abstract

The rapid increase in telemedicine coupled with recent advances in diagnostic artificial intelligence (AI) create the imperative to consider the opportunities and risks of inserting AI-based support into new paradigms of care. Here we build on recent achievements in the accuracy of image-based AI for skin cancer diagnosis to address the effects of varied representations of AI-based support across different levels of clinical expertise and multiple clinical workflows. We find that good quality AI-based support of clinical decision-making improves diagnostic accuracy over that of either AI or physicians alone, and that the least experienced clinicians gain the most from AI-based support. We further find that AI-based multiclass probabilities outperformed content-based image retrieval (CBIR) representations of AI in the mobile technology environment, and AI-based support had utility in simulations of second opinions and of telemedicine triage. In addition to demonstrating the potential benefits associated with good quality AI in the hands of non-expert clinicians, we find that faulty AI can mislead the entire spectrum of clinicians, including experts. Lastly, we show that insights derived from AI class-activation maps can inform improvements in human diagnosis. Together, our approach and findings offer a framework for future studies across the spectrum of image-based diagnostics to improve human–computer collaboration in clinical practice.

A systematic evaluation of the value of AI-based decision support in skin tumor diagnosis demonstrates the superiority of human–computer collaboration over each individual approach and supports the potential of automated approaches in diagnostic medicine.

Details

Title
Human–computer collaboration for skin cancer recognition
Author
Tschandl Philipp 1   VIAFID ORCID Logo  ; Rinner Christoph 2   VIAFID ORCID Logo  ; Apalla Zoe 3 ; Argenziano Giuseppe 4   VIAFID ORCID Logo  ; Codella Noel 5 ; Halpern, Allan 6 ; Janda Monika 7 ; Lallas Aimilios 3 ; Longo Caterina 8 ; Malvehy Josep 9 ; Paoli, John 10 ; Puig, Susana 11 ; Rosendahl, Cliff 12 ; Peter, Soyer H 13   VIAFID ORCID Logo  ; Zalaudek Iris 14 ; Kittler Harald 1   VIAFID ORCID Logo 

 Medical University of Vienna, ViDIR Group, Department of Dermatology, Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492) 
 Medical University of Vienna, Center for Medical Statistics, Informatics and Intelligent Systems (CeMSIIS), Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492) 
 Aristotle University of Thessaloniki, Department of Dermatology, Thessaloniki, Greece (GRID:grid.4793.9) (ISNI:0000000109457005) 
 University of Campania, Dermatology Unit, Naples, Italy (GRID:grid.4793.9) 
 IBM T. J. Watson Research Center, New York, USA (GRID:grid.481554.9) 
 Memorial Sloan Kettering Cancer Center, Dermatology Service, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952) 
 The University of Queensland, Centre for Health Services Research, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537) 
 University of Modena and Reggio Emilia, Dermatology Unit, Modena, Italy (GRID:grid.7548.e) (ISNI:0000000121697570); Azienda Unità Sanitaria Locale—IRCCS di Reggio Emilia, Centro Oncologico ad Alta Tecnologia Diagnostica-Dermatologia, Reggio Emilia, Italy (GRID:grid.7548.e) 
 IDIBAPS, Universitat de Barcelona, Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, Barcelona, Spain (GRID:grid.7548.e); Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER ER), Instituto de Salud Carlos III, Barcelona, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427) 
10  University of Gothenburg, Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden (GRID:grid.8761.8) (ISNI:0000 0000 9919 9582); Region Västra Götaland, Sahlgrenska University Hospital, Department of Dermatology and Venereology, Gothenburg, Sweden (GRID:grid.1649.a) (ISNI:000000009445082X) 
11  IDIBAPS, Universitat de Barcelona, Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, Barcelona, Spain (GRID:grid.1649.a); Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER ER), Instituto de Salud Carlos III, Barcelona, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427) 
12  The University of Queensland, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537) 
13  The University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537) 
14  Medical University of Trieste, Department of Dermatology, Trieste, Italy (GRID:grid.5133.4) (ISNI:0000 0001 1941 4308) 
Pages
1229-1234
Publication year
2020
Publication date
Aug 2020
Publisher
Nature Publishing Group
ISSN
10788956
e-ISSN
1546170X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2432264183
Copyright
© The Author(s), under exclusive licence to Springer Nature America, Inc. 2020.